A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation
Nature Communications2014Vol. 5(1)
Citations Over TimeTop 1% of 2014 papers
Raphaël Duivenvoorden, Jun Tang, David P. Cormode, Aneta J. Mieszawska, David Izquierdo‐Garcia, Canturk Ozcan, Maarten J. Otten, Neeha Zaidi, Mark E. Lobatto, Sarian M. van Rijs, Bram Priem, Emma L. Kuan, Catherine Martel, Bernd Hewing, Hendrik B. Sager, Matthias Nahrendorf, Gwendalyn J. Randolph, Erik S.G. Stroes, Valentı́n Fuster, Edward A. Fisher, Zahi A. Fayad, Willem J. M. Mulder
Related Papers
- → Lipoprotein Heterogeneity and its Effect on Apolipoprotein Assays(1990)11 cited
- → Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy(2012)9 cited
- → Apolipoprotein A-1 and apolipoprotein B containing lipoprotein particles in coronary patients treated with extracorporal low density lipoprotein precipitation (HELP)(1992)9 cited
- → PCV107 Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy(2012)
- → PCV63 TRENDS IN CONVERSION TO GENERIC ATORVASTATIN AMONG MEDICARE BENEFICIARY STATIN USERS(2020)